Institutul National De Boli Infectioase Prof.Dr.Matei Bals
- Address
- lock Available on a paid plan
Virus Diseases Research
At Institutul National De Boli Infectioase Prof.Dr.Matei Bals in Bucharest, the clinical trial portfolio focuses on virus diseases, with studies centered on COVID-19, chronic hepatitis B, chronic hepatitis D, and HIV-1. The research is designed to assess new treatments, understand antiviral effects, and support better management of infectious diseases.
- Studies in COVID-19 are evaluating whether new outpatient treatments can reduce hospitalization and death.
- Chronic hepatitis B research includes testing antiviral options in children, adolescents, and adults to improve safety and infection control.
- Chronic hepatitis D infection studies are examining treatment safety and the longer-term impact on liver disease progression.
- HIV-1 research is exploring new approaches aimed at expanding future antiviral treatment choices.
Overall, the site supports clinical research that combines antiviral therapy evaluation with efforts to improve disease outcomes across a range of serious viral infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 49 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 46 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1Gilead Sciences Inc.2active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Vir Biotechnology Inc.6trials
lock +6 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institutul National De Boli Infectioase Prof.Dr.Matei Bals
lock Showing 1 of 31 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3) | Mirum Pharmaceuticals Inc. | Phase IV | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 49 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Elebsiran | 6 | Unknown | 2022-06-16 | 2025-07-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.